Pink Sheet: Informa Pharma Intelligence – January 6, 2020

Nancy Bradish Myers, President & CEO at Catalyst Healthcare Consulting, explores how the Biden Administration FDA Commissioner pick will determine how significant agency reforms will be following the COVID-19 pandemic and all its lessons learned. It is an unusual opportunity to consider reforms. In the article she outlines the unique skill set that will be required of a future commissioner. Read the full article, “Biden’s FDA Commissioner Playbook Build on COVID Innovations To Modernize Agency” here.